Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
August 24, 2017
Adjuvant Capecitabine for Breast Cancer
Mutlu Hizal, Mehmet A N Şendur, Bülent Yalçin
The New England Journal of Medicine
|
August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Mutlu Hizal, Mehmet A N Sendur, Bulent Yalcin
Expert Opinion on Biological Therapy
|
September 14, 2019
An update on immunotherapy options for urothelial cancer
Burak Bilgin, Mehmet A N Sendur, Mutlu Hizal, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
February 6, 2019
Mutational status of lung cancer patients and survival outcomes for patients with limited brain metastases
Mutlu Hizal, Mehmet Ali Nahit Sendur, Burak Bilgin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 25, 2019
Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?
Mutlu Hizal, Mehmet Ali Sendur, Burak Bilgin, et al.
Current Medical Research and Opinion
|
January 17, 2020
A historical turning point for the treatment of advanced renal cell carcinoma: inhibition of immune checkpoint
Mutlu Hizal, Mehmet A N Sendur, Burak Bilgin, et al.
Scientific Reports
|
September 12, 2024
Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis
Mutlu Hizal, Abdurrahman Tufan, Ridvan Mercan, et al.
Clinical Rheumatology
|
January 20, 2015
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?
Mutlu Hizal, Cosimo Bruni, Eloisa Romano, et al.
Journal of Cancer Research and Therapeutics
|
March 19, 2019
Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization
Burak Bilgin, Mehmet Ali Nahit Sendur, Mutlu Hizal, et al.
Journal of Cancer Research and Clinical Oncology
|
February 2, 2021
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Burak Bilgin, Mehmet Ali Nahit Şendur, Şebnem Yücel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
August 24, 2017
Adjuvant Capecitabine for Breast Cancer
Mutlu Hizal, Mehmet A N Şendur, Bülent Yalçin
The New England Journal of Medicine
|
August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Mutlu Hizal, Mehmet A N Sendur, Bulent Yalcin
Expert Opinion on Biological Therapy
|
September 14, 2019
An update on immunotherapy options for urothelial cancer
Burak Bilgin, Mehmet A N Sendur, Mutlu Hizal, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
February 6, 2019
Mutational status of lung cancer patients and survival outcomes for patients with limited brain metastases
Mutlu Hizal, Mehmet Ali Nahit Sendur, Burak Bilgin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 25, 2019
Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?
Mutlu Hizal, Mehmet Ali Sendur, Burak Bilgin, et al.
Current Medical Research and Opinion
|
January 17, 2020
A historical turning point for the treatment of advanced renal cell carcinoma: inhibition of immune checkpoint
Mutlu Hizal, Mehmet A N Sendur, Burak Bilgin, et al.
Scientific Reports
|
September 12, 2024
Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis
Mutlu Hizal, Abdurrahman Tufan, Ridvan Mercan, et al.
Clinical Rheumatology
|
January 20, 2015
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?
Mutlu Hizal, Cosimo Bruni, Eloisa Romano, et al.
Journal of Cancer Research and Therapeutics
|
March 19, 2019
Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization
Burak Bilgin, Mehmet Ali Nahit Sendur, Mutlu Hizal, et al.
Journal of Cancer Research and Clinical Oncology
|
February 2, 2021
The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Burak Bilgin, Mehmet Ali Nahit Şendur, Şebnem Yücel, et al.
Page
of 3